BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	8,492	10,006	14,259	15,963	11,979	11,659
Market Cap Growth	-12.39%	-29.83%	-10.67%	33.26%	2.74%	1.68%
Enterprise Value	7,852	9,744	14,235	15,811	11,985	11,659
Last Close Price	43.95	52.46	75.71	83.80	66.15	64.78
PE Ratio	21.93	29.35	108.34	135.87	-	18.64
PS Ratio	3.69	4.39	7.51	9.18	8.79	8.56
PB Ratio	1.88	2.21	3.67	4.18	3.80	3.88
P/TBV Ratio	2.03	2.44	4.10	4.73	4.41	4.56
P/FCF Ratio	13.72	25.70	290.28	350.06	77.63	-
P/OCF Ratio	12.49	21.87	114.04	109.34	53.26	186.47
EV/Sales Ratio	3.46	4.28	7.50	9.09	8.79	8.56
EV/EBITDA Ratio	13.26	18.30	62.49	121.62	481.22	1186.81
EV/EBIT Ratio	15.06	21.40	97.60	348.42	-	-
EV/FCF Ratio	12.68	25.03	289.80	346.74	77.67	-
Debt / Equity Ratio	0.10	0.11	0.23	0.24	0.26	0.28
Debt / EBITDA Ratio	0.75	0.93	3.73	6.58	23.56	43.10
Debt / FCF Ratio	0.73	1.30	18.12	20.38	5.38	-
Net Debt / Equity Ratio	-0.14	-0.09	0.01	-0.04	0.03	0.02
Net Debt / EBITDA Ratio	-1.10	-0.76	0.21	-1.10	3.25	4.92
Net Debt / FCF Ratio	-1.05	-1.03	0.96	-3.12	0.52	-2.28
Asset Turnover	0.43	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.45	0.50	0.53	0.60	1.49	1.67
Quick Ratio	2.84	2.96	1.45	2.98	2.54	3.07
Current Ratio	4.83	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	9.07%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	6.15%	5.15%	1.76%	0.55%	-0.78%	-1.09%
Return on Invested Capital (ROIC)	10.50%	8.84%	3.50%	1.18%	-1.74%	-2.46%
Return on Capital Employed (ROCE)	10.40%	8.90%	3.30%	0.90%	-1.40%	-1.70%
Earnings Yield	4.56%	3.41%	0.92%	0.74%	-0.40%	5.37%
FCF Yield	7.29%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	-2.10%	-2.67%	-1.39%	-3.34%	4.61%	-7.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.